Catalent unveils OneBio Suite for biologics development

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/JK1991)
(Image: Getty/JK1991)

Related tags: Catalent, Biologics, BIO International Conference

Catalent is unveiling its OneBio Suite for the integrated development, manufacturing, and clinical supply of biologic drugs.

The company will announce the new suite during the BIO International Convention this week in Philadelphia, PA.

According to Catalent, OneBio was designed to address biologic development challenges by providing customers with a single contract, program manager, and development timeline.

“In OneBio, Catalent offers its partners the improved communications associated with streamlined program management and a single point of contact, reduced timelines brought about through parallel processing, and the increased flexibility of a global network of expertise and resources,”​ a Catalent spokesperson told us.

In early April, Catalent invested $5m​ in a new drug development center of excellence to expand its hot melt extrusion (HME) capabilities for formulation and drug delivery method optimization.

According to the company, the expansion enables Catalent to develop amorphous dispersions and controlled and modified drug delivery, such as controlled release for enhanced bioavailability.

Catalent also last month announced​ that it is installing new equipment to increase its formulation capabilities and capacity to manufacture controlled-release tablets and capsules.

The $40m investment will see the addition of a laser drill for osmotic drug delivery and stick pack dosage manufacturing capabilities at the company’s Winchester, KY-based facility.

Related news

Show more

Related products

show more

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 09-Jun-2021 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Integrated Solutions for Accelerated Time to Market

Integrated Solutions for Accelerated Time to Market

Piramal Pharma Solutions | 08-Jun-2021 | Technical / White Paper

Facing capacity constraints? Lock in your program now! With 14 sites around the world providing diverse services ranging from discovery to drug substance...

Transforming Clinical Development

Transforming Clinical Development

PerkinElmer | 01-Jun-2021 | Technical / White Paper

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...

Adapting supply chains to new ways of working

Adapting supply chains to new ways of working

World Courier | 01-Jun-2021 | Technical / White Paper

COVID-19 has changed the way we operate. We have adapted our supply chain solutions to meet our clients’ requirements while following World Courier standard...

Related suppliers

Follow us


View more